Table 1_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Image 1_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Table 4_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Table 3_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Table 5_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Supplementary file 1_Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III tria... by Huaxiang Liu (322464)

“…</p>Conclusion<p>Ivarmacitinib significantly reduces the need for adding/escalating medications compared to placebo, thereby potentially decreasing treatment burden. …”

Effect of dilution factor and replicate number on the reproducibility of αSyn^D seed concentration estimates in PD (A-D) and DLB (E-H) brain homogenates by ED RT-QuIC ass... by Ankit Srivastava (742990)

Table 1_A population-based registry study on psoriasis-associated burden of disease in Finland.docx by Liisa Ukkola-Vuoti (382651)

“…Work absences started to accumulate before the initiation of the first medication in the first biological cohort, followed by a subsequent decrease, while the accumulation remained modest and linear in shape among the switchers. …”

Post-marketing safety of panitumumab: a real-world pharmacovigilance study by Heli Wen (20459923)

“…Ileus was highlighted as a novel ADR in gastrointestinal disorders, with no significant age or sex differences.…”

Data Sheet 1_Pingers as a potential deterrent tool to mitigate Burmeister’s porpoise (Phocoena spinipinnis) bycatch while foraging nocturnally in the Humboldt Current System: a pil... by Diego Díaz (3286374)

“…The results show that the number of clicks and detection-positive minutes were significantly higher while the inter-click intervals and high click rate feeding buzz were significantly lower at night, indicating that Burmeister’s porpoises forage mainly nocturnally in this bay. …”

A Revealed Preference Approach to Identification and Inference in Producer-Consumer Models by Charles Gauthier (1451917)

“…Using data on shopping expenditures and shopping intensity from the NielsenIQ Homescan Dataset, I show that a doubling of shopping intensity decreases prices paid by about <math><mrow><mn>15</mn><mi>%</mi></mrow></math>. …”

Impact of mobility in a three-region system with heterogeneous epidemic conditions. by Mousumi Roy (8869412)

“…These simulations underscore that both human mobility and regional epidemic status jointly shape disease transmission dynamics. Mobility has a significant impact in heterogeneous epidemic scenarios, where differences in transmission intensity across regions can lead to outbreaks in low-risk areas through population movement. …”

<b><i>Assessment of Diseases’ Prevalence, Nutrition and Associated Factors in a Conflict-Affected Region: A Study in Leepa Valley, Azad Jammu and Kashmir, Pakistan</i></b> by Zoha Khan (19100603)

“…Objectives: To assess general health and nutritional status, any prevailing diseases and associated factors in residents of the Conflict-Affected Region of Leepa Valley, Azad Jammu and Kashmir, Pakistan. Methodology: A cross-sectional study was executed by circulating a self-structured questionnaire among the patients at a Medical Camp in Leepa as convenient sampling. …”

ELISA kit information. by Shuailin Li (11907158)

“…Furthermore, in AN-LSCs, travoprost treatment does not lead to a decrease in NF-κB and ADH7 protein levels.</p></div>…”

S1 Data - by Ergang Wang (1459321)

“…Meanwhile, plant extract-related treatments significantly increased plant physiological properties and TP (Total protein) content, and decreased the content of MDA (malondialdehyde) by 15.70% -36.59% and PRO (proline) by 30.13% -148.44%. …”

Supplementary file 1_Feasibility of repetitive transcranial magnetic stimulation on non-motor symptoms of spinocerebellar ataxia type 3: a secondary analysis of a randomized clinic... by Hua Wu (2707)

“…</p>Results<p>The results disclosed significant time effects for all the outcomes with post hoc comparisons showing differences of baseline and post-treatment evaluation, with decreases for PSQI, AIS, HARS, and HDRS as well as increase for MMSE and MoCA. …”

Hardness preference in <i>Drosophila</i> larvae, as a relevant cue for varying feeding substrates. by Nikita Komarov (11903342)

“…(B) Compression modulus of a range of agarose concentrations showing a decrease in compression modulus in successively lower agarose concentrations. …”

Western blot antibody information. by Shuailin Li (11907158)

“…Furthermore, in AN-LSCs, travoprost treatment does not lead to a decrease in NF-κB and ADH7 protein levels.</p></div>…”

Information on healthy and aniridia subjects. by Shuailin Li (11907158)

“…Furthermore, in AN-LSCs, travoprost treatment does not lead to a decrease in NF-κB and ADH7 protein levels.</p></div>…”

qPCR primers information. by Shuailin Li (11907158)

“…Furthermore, in AN-LSCs, travoprost treatment does not lead to a decrease in NF-κB and ADH7 protein levels.</p></div>…”